Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion Lymphoma
This study has been completed.
Study NCT00217503
Information provided by National Cancer Institute (NCI)
First Received on September 20, 2005.
Last Updated on February 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
